Highlights Piramal Pharma Limited

Equities

PPLPHARMA

INE0DK501011

Delayed NSE India S.E. Other stock markets 06:29:22 2024-06-04 EDT			5-day change	1st Jan Change
144.8 ^INR	-3.21%		-3.47%	+4.29%

05-14	Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy	MT
05-13	Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Piramal Pharma Limited Recommends Final Dividend for the Financial Year Ended 31 March 2024	05-10	CI
Piramal Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-10	CI
Piramal Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-10	CI
Piramal Pharma Gets US FDA's Establishment Inspection Report for Riverview, US Facility	04-17	MT
Piramal Pharma Forays into Men Grooming Products	04-10	MT
Piramal Pharma Limited Announces the Launch of BOHEM Product Range	04-10	CI
Piramal Pharma Turns to Profit in Fiscal Q3	01-31	MT
Piramal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01-30	CI
Piramal Pharma Solutions Commences Opening of Its Antibody-Drug Conjugate Manufacturing Expansion in Grangemouth, Scotland	12-18	CI
Piramal Pharma Gets US FDA's EIR Report After Bethlehem, USA Unit Inspection	11-09	MT
Piramal Pharma Swings to Profit in Fiscal Q2	23-10-30	MT
Piramal Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-27	CI
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities At Ahmedabad Discovery Services Site	23-10-16	CI
Piramal Pharma Gets Two Observations from US FDA After Inspection of US Facility	23-09-28	MT
Piramal Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-03	CI
Piramal Pharma Gets SEBI Nod for INR10.50 Billion Rights Issue	23-07-19	MT
Canada's CDPQ Sells Stake in Piramal Pharma	23-06-19	MT
Piramal Pharma's Consolidated Profit Slumps in Fiscal Q4	23-05-26	MT
Piramal Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-24	CI
US FDA Concludes Inspection at Piramal Pharma's Sellersville Manufacturing Unit	23-04-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Piramal Pharma Limited

Equities

PPLPHARMA

INE0DK501011

Highlights

Filters